Mirae Asset Global ETFs Holdings
LXEO icon

Mirae Asset Global ETFs Holdings’s Lexeo Therapeutics LXEO Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$190K Buy
40,485
+3,414
+9% +$18.5K ﹤0.01% 2509
2026
Q1 		$209K Buy
37,071
+1,814
+5% +$12.9K ﹤0.01% 2340
2025
Q4 		$349K Buy
35,257
+23,804
+208% +$217K ﹤0.01% 2076
2025
Q3 		$76K Sell
11,453
-2,024
-15% -$9.79K ﹤0.01% 2791
2025
Q2 		$54.2K Sell
13,477
-624
-4% -$2.05K ﹤0.01% 2864
2025
Q1 		$48.9K Buy
14,101
+624
+5% +$2.76K ﹤0.01% 2857
2024
Q4 		$88.7K Buy
13,477
+608
+5% +$4.79K ﹤0.01% 2746
2024
Q3 		$116K Buy
12,869
+7,988
+164% +$95.3K ﹤0.01% 2647
2024
Q2 		$78.3K Buy
+4,881
New +$70.9K ﹤0.01% 2666

Other funds holding LXEO

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's LXEO Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Lexeo Therapeutics (LXEO) stake by 9.2% in Q2 2026, buying an estimated $18.5K and bringing the position to 40,485 shares worth $190K. The position accounts for ﹤0.01% of the portfolio, ranked #2509.

Mirae Asset Global ETFs Holdings first reported a position in LXEO in Q2 2024 and has held it in 9 quarters since. The position peaked at $349K in Q4 2025. 141 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 40,485 shares of Lexeo Therapeutics worth $190K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 3,414 Lexeo Therapeutics shares in Q2 2026, an estimated $18.5K.
  • Lexeo Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2509 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Lexeo Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Lexeo Therapeutics position peaked at $349K in Q4 2025.
  • 141 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.